Synovial Sarcoma Registry / Biospecimen Repository
Part of paid clinical trials in Philadelphia, Pennsylvania.
- Sponsor
- Children's Hospital of Philadelphia
- Study ID
- NCT05910307
- Status
- Recruiting
Conditions
- Synovial Sarcoma
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Study Details
The purpose of this study is to collect and store data and samples for future research to attempt to improve outcomes for patients with synovial sarcoma. The future research will involve various types of genetic testing. Participants will be asked to allow access to medical records and leftover tumor tissue and may be asked to give a blood or saliva sample. Participants will also be asked to completed questionnaires about their medical history and may be contacted every 6 to 12 months for updates for up to 10 years.
Key Dates
- Start date
- Jun 12, 2023
- Status verified
- Jun 2026
- Primary completion
- Jun 30, 2028
- Completion
- Jun 30, 2033
Study Design
- Enrollment
- 1,000 participants (estimated)
Primary Outcome Measure
Number of patients with synovial sarcoma [ Time Frame: Up to 10 years ]
Central Contacts
- Lauren Gutstein267-425-2029
- James Robinson215-590-2053
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 |
Find similar trials in Philadelphia, PA
By research site
Related Studies
- Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)PHASE3 · Recruiting · Advenchen Laboratories, LLC · Phoenix, Arizona
- SPEARHEAD-3 Pediatric StudyPHASE1/PHASE2 · Recruiting · USWM CT, LLC · Palo Alto, California
- HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced SarcomaPHASE1 · Recruiting · Baylor College of Medicine · Houston, Texas
- Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1PHASE1 · Recruiting · M.D. Anderson Cancer Center · Houston, Texas